Newsroom
At Memorial Sloan Kettering Cancer Center, our world-renowned cancer researchers, oncologists, clinicians, and scientists are constantly advancing our knowledge about cancer. Our discoveries are improving treatment and care for patients here and all over the world. On this page, you will find news & information about our latest groundbreaking cancer science, exceptional patient care and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries and for story ideas.
Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the Northeast, the number two cancer hospital in the nation, and the number one hospital for urology care by U.S. News & World Report in its annual Best Hospitals list. MSK has held its position as a top-two cancer hospital in the U.S. and the best cancer center in the Northeast since these rankings were established 35 years ago.
Over the last seven and a half decades, researchers at the Sloan Kettering Institute have made important contributions to the fundamental understanding of human biology, as well as driven practice-changing innovations in the treatment of cancer.
Press Releases
Researchers from Memorial Sloan Kettering Cancer Center to present the latest advances in blood cancer during The American Society of Hematology 2024 annual meeting.
Ivan Maillard, MD, PhD, has been named Head of the Division of Hematologic Malignancies within the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).
Dr. Deb Schrag, Chair of the Department of Medicine, and Dr. Lorenz Studer, Director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center (MSK), have been elected to the National Academy of Medicine (NAM), one of the highest honors bestowed upon scientists worldwide.
Articles
Learn about Dana and the uterine transposition surgery at MSK in NYC, that enabled her to give birth to a baby named Hudson, who made history.
Metastasis remains the primary challenge to reducing cancer deaths worldwide. A new MSK study is providing unique insights that researchers say point to new therapeutic opportunities.
Learn how a three-drug treatment appears to be very effective for ER+, HER2- breast cancers.
2023 Annual Report: Ending Cancer for Life
Sidelining Side Effects
Improving patients’ quality of life with less toxic treatments.
See how MSK helps patients live their best lives during and after treatment
Seeking a Match for Everyone
Helping people with diverse ancestries find lifesaving donors.
Read about the techniques offering hope to patients
Coming Full Circle
MSK saved her life as a child — now she supports vital research at MSK.
Read Madeleine's story